IBEC celebrates COPD breakthroughs on World COPD Day
IBEC’s Biomedical Signal Processing and Interpretation (BIOSPIN) group have published a paper with King’s College London that offers new techniques to monitor COPD patients by non-invasive methods.
IBEC’s Biomedical Signal Processing and Interpretation (BIOSPIN) group have published a paper with King’s College London that offers new techniques to monitor COPD patients by non-invasive methods.COPD – chronic obstructive pulmonary disease – is a progressive lung condition with no cure in which the patient’s airways become narrowed. Together with other mechanical abnormalities, airways obstruction increases the load on the respiratory muscles. This, in combination with respiratory muscle weakness in COPD patients, increases load-capacity imbalance and contributes to breathlessness. The IBEC group’s paper elucidates a new way of assessing inspiratory muscle function using mechanomyography, a non-invasive measure of muscle vibration associated with muscle contraction, jointly with surface electromyography.
The nanoBio&Med2018 International Conference opened today with IBEC Director Josep Samitier chairing the first round of talks, in which group leader Samuel Sanchez is the first speaker.
Researchers at IBEC and IDIBELL have developed a light-regulated molecule that could improve chemotherapy treatments by controlling the activity of anticancer agents.
Today Spain’s Severo Ochoa Centres of Excellence – including IBEC – and the María de Maeztu Units of Excellence are at the CNIO in Madrid for 100xCiencia.3, the annual event of the